Market cap
$11,346 Mln
Revenue (TTM)
$1,215 Mln
P/E Ratio
62.4
P/B Ratio
5.4
Div. Yield
0.4 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 3.14 | 1.33 | -0.38 | 2.25 | 5.47 |
| EBIT | -8.98 | 427.63 | 130.05 | -11.70 | 8.70 |
| Net Profit | 6.96 | 408.92 | 147.77 | -13.92 | 2.97 |
| EPS | 6.92 | 406.46 | 155.17 | -13.02 | 5.94 |
| Book Value | -- | -- | 9.00 | 3.40 | 7.07 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Jun-26 | Jun-25 | Jun-24 |
| EBIT-Margin
| 15.47 | 21.09 | 20.25 | 8.77 | 17.38 |
| Net Margin
| -- | 24.14 | -- | -- | -- |
| Return on equity
| 7.02 | 10.65 | 9.03 | 3.68 | 8.33 |
| Return on Capital
| 5.84 | 8.78 | 7.64 | 3.03 | 6.85 |
| Return on Assets
| 5.34 | 7.91 | 6.95 | 2.79 | 6.29 |
| Debt to Equity (x)
| -- | -- | 0.14 | 0.23 | 0.20 |
Profitability
ROCE
7.64
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
7.64
|
3.03
|
6.85
|
12.82
|
13.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
9.03
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
9.03
|
3.68
|
8.33
|
15.55
|
16.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
6.95
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
6.95
|
2.79
|
6.29
|
11.56
|
11.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
20.25
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
20.25
|
8.77
|
17.38
|
30.78
|
28.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
14.97
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
14.97
|
6.02
|
14.50
|
24.02
|
24.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.00
--
Year on year growth in net sales
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
0.00
|
0.05
|
0.02
|
0.03
|
0.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
130.05
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
130.05
|
-46.89
|
-42.43
|
11.89
|
92.87
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
147.77
--
Year on year growth in profit after tax
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
147.77
|
-56.34
|
-41.07
|
4.86
|
93.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
1.46
--
Year on year growth in earnings per share
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
1.46
|
-0.55
|
-0.41
|
0.06
|
0.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.14
--
Total debt / Net worth
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
0.14
|
0.23
|
0.20
|
0.23
|
0.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
0.01
|
0.01
|
0.01
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.55
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
4.55
|
3.46
|
3.87
|
4.84
|
3.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
3.35
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
3.35
|
2.38
|
2.75
|
3.50
|
2.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
45.53
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
45.53
|
12.57
|
12.80
|
31.20
|
27.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
18.15
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
18.15
|
16.96
|
20.83
|
19.22
|
17.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.46
--
Sales / Average Total Assets
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
0.46
|
0.46
|
0.43
|
0.46
|
0.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
64.24
--
Average Debtors / Sales * 365
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
64.24
|
67.12
|
72.46
|
66.36
|
56.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
169.11
--
Average Inventory / Sales * 365
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
169.11
|
157.03
|
164.82
|
155.68
|
134.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
22.83
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
22.83
|
26.92
|
29.85
|
29.64
|
33.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
210.51
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
210.51
|
197.23
|
207.42
|
192.40
|
157.96
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
61.00
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
61.00
|
109.18
|
68.47
|
46.33
|
208.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
5.26
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
5.26
|
4.18
|
5.56
|
6.72
|
33.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
32.37
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
Bio-Techne Corp (TECH)
|
32.37
|
38.25
|
37.61
|
29.46
|
137.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|